Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson Disease
A Pilot Phase II Double-Blind, Placebo-Controlled, Tolerability and Dosage Finding Study of Isradipine CR as a Disease Modifying Agent in Patients With Early Parkinson Disease A Pilot Phase II Double-Blind, Placebo-Controlled, Tolerability and Dosage Finding Study of Isradipi ...
Michael J. Fox Foundation for Parkinson's Research;Northwestern University Dixon Fund;The Parkinson Study Group Michael J. Fox Foundation for Parkinson's Research;Northwestern University Dixon Fund;The Parkinson ...